Viyash Scientific Reports Record Q4 FY26 Results: EBITDA Exceeds Rs 200 Cr
Viyash Scientific Limited, formerly known as Sequent Scientific Limited, announced its financial results for the period ending March 31, 2026. The company, which operates across Formulations, APIs, and CDMO Services for human and animal health, reported that Q4 FY26 marked the strongest quarter in the company's history.The consolidated financial highlights show significant year-over-year growth across key metrics.MetricQ4 FY26 (₹ in millions)Q4 FY25 (₹ in millions)Growth %FY26 (₹ in millions)FY25 (₹ in millions)Growth %Revenues9,2007,72319.1%34,20330,06813.8%EBITDA*2,0011,22163.9%7,0254,40059.6%EBITDA*%21.7%15.8%20.5%14.6%--...